Stock Taper
EARNINGS CALL ARCHIVE 3 CALLS ON FILE
SY — So-Young International Inc.
NASDAQ
FULL STOCK PAGE →

Summary of So-Young's Q4 2025 Earnings Call

MAR 25, 2026 2 MIN READ
REVENUE
$454.4M +17.5%
NET MARGIN
-23.6% -7.0 PTS
EPS
-$0.81 -65.3%
FREE CASH FLOW
-$302.0M

1Key Financial Results and Metrics

Total Revenue: RMB 451 million, up 25% year-over-year, marking a record high for quarterly revenue.

Aesthetic Center Revenue: RMB 248 million, up over 205% year-over-year, contributing over 50% of total revenue for the first time.

Net Loss: RMB 108.8 million, an improvement from RMB 607.6 million in Q4 2024. Non-GAAP net loss was RMB 93.4 million.

Cash Position: RMB 936.4 million, down from RMB 1,253.2 million in 2024, reflecting investments in expansion.

Average Revenue per Center: Mature centers generated RMB 102.5 million, while growth centers contributed RMB 89 million.

2Strategic Updates and Business Highlights

Expansion: Opened 49 medical aesthetic centers, becoming the largest chain in China by center count. Plans to open at least 35 new centers in 2026, focusing on core cities and second-tier markets.

Operational Efficiency: 25 centers achieved profitability in Q4, with 39 generating positive operating cash flow.

Service Delivery Enhancements: Expanded physician team to 211, with a focus on quality and compliance, including a new initiative for physician recruitment and training.

Supply Chain Development: Collaborated with 18 top-tier suppliers, enhancing procurement capabilities and product offerings.

3Forward Guidance and Outlook

2026 Revenue Expectations: Anticipate aesthetic treatment services revenue between RMB 258 million and RMB 278 million, representing year-over-year growth of 171.2% to 181.3%.

Focus Shift: Transitioning from rapid expansion to balancing growth with profitability, with an emphasis on improving gross margins and operational efficiency.

4Bad News, Challenges, or Points of Concern

Declining Segments: Revenue from information and reservation services decreased by 26.8%, and sales of medical products fell by 19.9%, indicating potential weaknesses in these areas.

Increased Costs: Cost of revenues rose significantly, particularly in aesthetic treatment services, which may pressure margins.

Cash Decrease: The reduction in cash reserves could limit flexibility for future investments or operations.

5Notable Q&A Insights

Gross Margin Prospects: Management highlighted plans to optimize center openings and consumable costs to enhance margins.

Performance in Second-Tier Cities: Centers in these areas are performing well, with revenue growth comparable to first-tier cities, and showing higher margins due to lower operational costs.

Customer Acquisition Costs: Maintained below 10% of revenue, supported by a referral model and co-branding initiatives with well-known IPs to enhance brand equity.

Core Member Growth: Core members showed strong retention and spending, with plans to expand product offerings and optimize membership benefits to increase lifetime value. This summary encapsulates the key points from So-Young's Q4 2025 earnings call, providing a clear overview of the company's financial health, strategic direction, and market challenges.

SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT